Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fesoterodine
Drug ID BADD_D00891
Description Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
Indications and Usage For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
Marketing Status approved
ATC Code G04BD11
DrugBank ID DB06702
KEGG ID D07226
MeSH ID C526675
PubChem ID 6918558
TTD Drug ID D00BLL
NDC Product Code 47621-025; 50370-0047
UNII 621G617227
Synonyms fesoterodine | toviaz | fesoterodine fumarate
Chemical Information
Molecular Formula C26H37NO3
CAS Registry Number 286930-02-7
SMILES CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hypoaesthesia oral17.02.06.021; 07.05.05.0030.000496%Not Available
Cognitive disorder19.21.02.001; 17.03.03.0030.004416%
Hepatic enzyme increased13.03.04.028--Not Available
Freezing phenomenon17.01.05.0060.000496%Not Available
Bladder disorder20.03.01.0020.002431%Not Available
Cardiac disorder02.11.01.0030.001340%Not Available
Infestation23.11.01.002; 11.09.01.001--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Spinal disorder15.02.04.0230.000496%Not Available
Inner ear disorder04.04.02.002--Not Available
Parkinson's disease17.01.05.0100.001985%Not Available
Urinary tract obstruction20.08.01.0040.001736%
Obstructive airways disorder22.03.01.011--Not Available
Hepatobiliary disease09.01.08.003--Not Available
Renal impairment20.01.03.0100.002481%Not Available
Mixed liver injury09.01.07.0150.000744%Not Available
Functional gastrointestinal disorder07.11.01.016--Not Available
Bladder obstruction20.03.01.0120.000744%Not Available
Cardiac failure chronic02.05.01.0090.000496%Not Available
Postrenal failure20.01.03.0210.000496%Not Available
Communication disorder19.19.01.0080.000496%Not Available
Multiple system atrophy24.06.03.013; 17.02.10.0230.000496%Not Available
Stress urinary incontinence20.02.02.0220.001687%Not Available
Drug ineffective for unapproved indication12.09.02.002; 08.06.01.0380.001935%Not Available
Gait inability17.02.05.069; 08.01.02.0110.001340%Not Available
Hypotonic urinary bladder20.03.03.010; 17.05.01.0290.000744%Not Available
Illness08.01.03.0910.002183%Not Available
Therapeutic product effect decreased08.06.01.0500.002778%Not Available
Therapeutic product effect delayed08.06.01.0510.000496%Not Available
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages